India, May 27 -- In a country where cardiac care costs continue to burden millions, Ahmedabad-based Medkart has introduced a game-changing innovation: India's first room-temperature stable generic Nicorandil tablets, making heart medication more accessible, affordable, and logistically convenient.

This innovation eliminates the need for cold-chain storage, reducing logistical challenges and making the medication more accessible and affordable for patients across diverse regions.

Nicorandil is widely prescribed for the treatment of chronic stable angina. Due to its sensitivity to temperature and humidity, its storage has traditionally required stringent cold-chain logistics. This requirement often poses significant challenges, especially...